Monopar Therapeutics Inc. · NASDAQ:MNPR
Adage Capital Management, L.P.'s stake in Monopar Therapeutics Inc. fell to 4.76% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 12, 2026
Adage Capital Management, L.P.'s stake in Monopar Therapeutics Inc. fell to 4.76%, 324,195 shares, as a passive investor on Jun 30, 2026. Filed Aug 12, 2026 (Schedule 13G/A).
- Stake
- 4.76%
- Shares
- 324,195
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 4.76% | 324,195 |
| Robert Atchinson | 4.76% | 324,195 |
| Phillip Gross | 4.76% | 324,195 |
Source
Related
- Monopar Therapeutics Inc.
- Adage Capital Management, L.P.
- Monopar Therapeutics Inc. shareholders
- Schedule 13G/A · Adage Capital Management, L.P. · May 13, 2026
- Schedule 13G · Adage Capital Management, L.P. · Feb 12, 2025
- Form 4 · Robinson Chandler · Oct 20, 2026
- Form 4 · Starr Christopher M · Oct 5, 2026
- Form 4 · Cittadine Andrew · Oct 2, 2026
- Form 4 · Vu Quan Anh · Oct 2, 2026
- Form 4 · Robinson Chandler · Oct 2, 2026